CAS 888216-25-9
:Ganetespib
Description:
Ganetespib is a small molecule inhibitor primarily known for its role as a heat shock protein 90 (HSP90) inhibitor. It is classified as an antineoplastic agent, which means it is used in cancer treatment due to its ability to disrupt the function of HSP90, a chaperone protein that assists in the proper folding and stabilization of various client proteins involved in cancer cell proliferation and survival. Ganetespib has shown potential in preclinical and clinical studies for treating various types of cancers, including lung cancer and other solid tumors. The compound is characterized by its specific molecular structure, which allows it to bind to the ATP-binding site of HSP90, thereby inhibiting its activity. This inhibition leads to the degradation of client proteins that are crucial for tumor growth and survival. Ganetespib is typically administered via intravenous injection and has been the subject of various clinical trials to evaluate its efficacy and safety profile in cancer therapy.
Formula:C20H20N4O3
Synonyms:- 3-(2,4-Dihydroxy-5-isopropylphenyl)-4-(1-methylindol-5-yl)-5-hydroxy-4H-1,2,4-triazole
- 3H-1,2,4-Triazol-3-one, 5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-2,4-dihydro-4-(1-methyl-1H-indol-5-yl)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Ganetespib
CAS:Ganetespib (STA-9090) is a synthetic small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.Formula:C20H20N4O3Purity:98% - 99.95%Color and Shape:SolidMolecular weight:364.42,4-Dihydro-5-[2,4-dihydroxy-5-isopropylphenyl]-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one
CAS:<p>2,4-Dihydro-5-[2,4-dihydroxy-5-isopropylphenyl]-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one</p>Formula:C20H20N4O3Purity:By hplc: 98% (Typical Value in Batch COA)Color and Shape: white solidMolecular weight:364.40g/molGanetespib
CAS:<p>Heat shock protein 90 (HSP90) inhibitor</p>Formula:C20H20N4O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:364.4 g/mol




